Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,098 | 4 | 59.9% |
| Honoraria | $5,789 | 3 | 28.7% |
| Food and Beverage | $1,386 | 25 | 6.9% |
| Travel and Lodging | $745.29 | 4 | 3.7% |
| Education | $177.99 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $7,922 | 13 | $0 (2024) |
| PharmaEssentia USA Corporation | $5,750 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,363 | 1 | $0 (2024) |
| Blueprint Medicines Corporation | $1,803 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,160 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $235.42 | 2 | $0 (2021) |
| ABBVIE INC. | $228.32 | 2 | $0 (2024) |
| SOBI, INC | $167.31 | 2 | $0 (2024) |
| Genentech USA, Inc. | $116.86 | 1 | $0 (2019) |
| CTI BioPharma Corp. | $109.37 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,712 | 18 | Incyte Corporation ($7,890) |
| 2023 | $2,544 | 7 | PharmaEssentia USA Corporation ($2,300) |
| 2022 | $1,204 | 2 | GlaxoSmithKline, LLC. ($1,160) |
| 2021 | $312.78 | 3 | AstraZeneca Pharmaceuticals LP ($235.42) |
| 2020 | $95.00 | 1 | Astellas Pharma US Inc ($95.00) |
| 2019 | $116.86 | 1 | Genentech USA, Inc. ($116.86) |
| 2018 | $105.86 | 1 | AbbVie, Inc. ($105.86) |
| 2017 | $106.01 | 5 | Astute Medical, Inc. ($106.01) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,160.00 | General |
| 09/08/2022 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $43.69 | General |
| Category: Oncology | ||||||
| 12/11/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $127.41 | General |
| 12/11/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $108.01 | General |
| Category: Oncology | ||||||
| 12/10/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $77.36 | General |
| 01/23/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $95.00 | General |
| 12/06/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $116.86 | General |
| 11/30/2018 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $105.86 | General |
| Category: Virology | ||||||
| 06/12/2017 | Astute Medical, Inc. | NephroCheck Test (Device) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Nephrology | ||||||
| 05/12/2017 | Astute Medical, Inc. | NephroCheck Test (Device) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: Nephrology | ||||||
| 05/11/2017 | Astute Medical, Inc. | NephroCheck Test (Device) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Nephrology | ||||||
| 05/10/2017 | Astute Medical, Inc. | NephroCheck Test (Device) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Nephrology | ||||||
| 05/04/2017 | Astute Medical, Inc. | NephroCheck Test (Device) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 131 | 159 | $79,982 | $13,203 |
| 2022 | 5 | 112 | 222 | $72,860 | $14,960 |
| 2021 | 6 | 114 | 253 | $87,973 | $20,100 |
| 2020 | 1 | 15 | 75 | $17,625 | $4,415 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 61 | $27,154 | $4,302 | 15.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 35 | $21,964 | $3,833 | 17.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $18,459 | $3,441 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 39 | $12,405 | $1,627 | 13.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 75 | $24,463 | $6,036 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 43 | $18,115 | $3,027 | 16.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 55 | $12,548 | $2,970 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 36 | $10,681 | $1,570 | 14.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $7,053 | $1,357 | 19.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 73 | $24,500 | $6,001 | 24.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 84 | $19,612 | $4,806 | 24.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 44 | $17,060 | $3,439 | 20.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 21 | $10,663 | $2,472 | 23.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $10,512 | $2,026 | 19.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 16 | 16 | $5,626 | $1,356 | 24.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 75 | $17,625 | $4,415 | 25.0% |
About Dr. Anthony Hunter, M.D
Dr. Anthony Hunter, M.D is a Hematology & Oncology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1053731612.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Hunter, M.D has received a total of $20,196 in payments from pharmaceutical and medical device companies, with $15,712 received in 2024. These payments were reported across 38 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($12,098).
As a Medicare-enrolled provider, Hunter has provided services to 372 Medicare beneficiaries, totaling 709 services with total Medicare billing of $52,678. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Atlanta, GA
- Active Since 04/22/2014
- Last Updated 12/29/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1053731612
Products in Payments
- BESREMI (Drug) $5,750
- SCEMBLIX (Drug) $2,363
- JAKAFI (Drug) $189.68
- CREON (Drug) $122.46
- Vonjo (Drug) $109.37
- CALQUENCE (Drug) $108.01
- NephroCheck Test (Device) $106.01
- Venclexta (Drug) $105.86
- DOPTELET (Drug) $84.32
- Gamifant (Drug) $82.99
- SARCLISA (Biological) $43.69
- AYVAKIT (Drug) $38.84
- IMBRUVICA (Drug) $19.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Atlanta
Dr. Jonathon Cohen, M.d, M.D
Hematology & Oncology — Payments: $330,523
Dr. Ajay Nooka, M.d., M.p.h.,F.a.c.p, M.D., M.P.H.,F.A.C.P
Hematology & Oncology — Payments: $256,358
Dr. Rodolfo Bordoni, Md, MD
Hematology & Oncology — Payments: $240,507
Dr. Mehmet Bilen, M.d, M.D
Hematology & Oncology — Payments: $134,196
Olatunji Alese, M.d, M.D
Hematology & Oncology — Payments: $131,083
Dr. Carlos Franco, Md, MD
Hematology & Oncology — Payments: $115,439